Bruce Beutler

Toll-like receptors (TLRs) are proteins on the surface and inside of immune cells that act as molecular sensors, recognizing telltale molecules from bacteria, viruses, and fungi. Bruce Beutler discovered that a specific receptor, TLR4, is the mechanism by which immune cells detect lipopolysaccharide (LPS)—a component of gram-negative bacteria that triggers inflammation and septic shock.

Beutler shared the 2011 Nobel Prize in Physiology or Medicine with Jules Hoffmann and Ralph Steinman. He and Hoffmann were recognized for their discoveries concerning the activation of innate immunity, specifically how immune cells first detect invading pathogens through receptor systems like Toll-like receptors.

Beutler used a chemical mutagenesis approach to create random mutations in mice, then screened them for animals that were resistant to LPS-induced septic shock. By tracing the resistance to a specific gene, he pinpointed TLR4 as the receptor responsible for detecting bacterial LPS, definitively linking a specific receptor to pathogen recognition in mammals.

Innate immunity is the body's first, rapid-response defense that detects broad patterns shared by many pathogens, which is exactly the system Beutler's Toll-like receptor work illuminated. Adaptive immunity, in contrast, involves B cells and T cells that produce a slower but highly specific response with immunological memory; Beutler's co-laureate Ralph Steinman was recognized for his work on dendritic cells, which bridge the two systems.